TuisUTHR • NASDAQ
add
United Therapeutics Corporation
Vorige sluiting
$367,36
Dagwisseling
$367,90 - $374,02
Jaarwisseling
$208,62 - $417,82
Markkapitalisasie
16,65 mjd USD
Gemiddelde volume
356,09 k
P/V-verhouding
16,39
Dividend-opbrengs
-
Primêre beurs
NASDAQ
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (USD) | Sep. 2024info | J/J-verandering |
|---|---|---|
Inkomste | 748,90 m | 22,89% |
Bedryfskoste | 257,60 m | 21,34% |
Netto inkomste | 309,10 m | 15,51% |
Netto winsgrens | 41,27 | -6,01% |
Wins per aandeel | 7,07 | 31,44% |
EBITDA | 427,30 m | 25,57% |
Effektiewe belastingkoers | 20,46% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (USD) | Sep. 2024info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 3,33 mjd | 15,68% |
Totale bates | 7,12 mjd | 1,42% |
Totale aanspreeklikheid | 1,02 mjd | -22,06% |
Totale ekwiteit | 6,10 mjd | — |
Uitstaande aandele | 44,64 m | — |
Prys om te bespreek | 2,69 | — |
Opbrengs op bates | 14,74% | — |
Opbrengs op kapitaal | 16,07% | — |
Kontantvloei
Netto kontantverandering
| (USD) | Sep. 2024info | J/J-verandering |
|---|---|---|
Netto inkomste | 309,10 m | 15,51% |
Kontant van bedrywe | 377,20 m | 8,95% |
Kontant van beleggings | -114,90 m | 63,34% |
Kontant van finansiering | -64,10 m | -943,42% |
Netto kontantverandering | 198,20 m | 390,59% |
Beskikbare kontantvloei | 248,31 m | 31,99% |
Meer oor
United Therapeutics Corporation is an American publicly traded biotechnology company and public benefit corporation listed on the NASDAQ under the symbol UTHR. It develops novel, life-extending technologies for patients in the areas of lung disease and organ manufacturing. United Therapeutics is co-headquartered in Silver Spring, Maryland and Research Triangle Park, North Carolina, with additional facilities in Magog and Bromont, Quebec; Melbourne and Jacksonville, Florida; Blacksburg, Virginia; and Manchester, New Hampshire. Wikipedia
Gestig
1996
Webwerf
Werknemers
1 168
